LYNOZYFIC: payments to doctors
Payments that named LYNOZYFIC as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $534K
- Providers
- 1,448
- Transactions
- 1,976
- Average per transaction
- $270
The per-transaction average — $270 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,448 providers the average total is $369, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $360,116 | 67.5% |
| Regeneron | $173,603 | 32.5% |